The online community for the biotech industry of the Netherlands.

Although the Netherlands biotechnology sector is not as large as some of Europe’s leaders, they are still making a name for themselves. NederlandBio has become a successful European Hotbed Community. Part of the Netherlands’ success has been its highly educated population and large scientific community. The amount of venture capital in NederlandBio has contributed to its status as a contender among larger biotechnology markets. NederlandBio is expected to continue flourishing and increasing its influence in the global biopharmaceutical sector.

Join the World Discussion Forum


Hotbed News
Self-Powered Rocket Nanovesicles To Ferry Drugs Around Body Able To Open And Close Using External Magnets, Radboud University Study Monday, September 29, 2014
Royal Philips Electronics N.V. (PHG) BlueControl Uses Light To Control Psoriasis Symptoms Friday, October 03, 2014
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises Monday, September 29, 2014
BioPharm Executive: Building Biotech's Next Boom Thursday, September 25, 2014
Your Brain On Snacks: Brain Stimulation Affects Craving And Consumption, University Of Waterloo Study Tuesday, September 16, 2014
ProSensa Holding N.V. (RNA) Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy Monday, October 13, 2014
ProSensa Holding N.V. (RNA) Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy Friday, October 10, 2014
Synthon Pharmaceuticals Announces Filing Of Glatiramer Acetate 40 Mg/Ml ANDA Containing A Paragraph IV Certification Thursday, October 09, 2014
Biotech Venture Capital Firm Aglaia Launches New $65 Million Oncology Fund Thursday, October 16, 2014
Agendia BV Appoints Jan Egberts, M.D., As CEO Thursday, October 02, 2014
12345678910